CompletedNot Applicable

Dexmedetomidine Versus Hyalase Treatment of Carpal Tunnel Syndrome

Egypt60 participantsStarted 2022-04-01

Plain-language summary

Carpal tunnel syndrome (CTS) is a common peripheral entrapment neuropathy, this study aims to investigate if, and to what extent hydro-dissection hyalase and saline versus dexmedetomidine upon the median nerve could offer symptoms and clinical improvement

Who can participate

Age range18 Years – 60 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * adult patients * complaining of carpal tunnel syndrome of 3 month duration or more * diagnosed axonal neuropathy using electrodiagnosis , nerve conduction study Exclusion Criteria: * • patient refusal infection at the site of intervention * local anesthetic allergy

What they're measuring

Pain alleviation

Timeframe: 6 months

Trial details

NCT IDNCT05280223

SponsorAssiut University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-06-30

View on ClinicalTrials.gov More Carpal Tunnel Syndrome trials